Potential medicinal plants for CNS disorders: an overview
@article{Kumar2006PotentialMP, title={Potential medicinal plants for CNS disorders: an overview}, author={Vikas Kumar}, journal={Phytotherapy Research}, year={2006}, volume={20} }
Although very few drugs are currently approved by regulatory authorities for treating multi‐factorial ailments and disorders of cognition such as Alzheimer's disease, certain plant‐derived agents, including, for example, galantamine and rivastigmine (a semi‐synthetic derivative of physostigmine) are finding an application in modern medicine. However, in Ayurveda, the Indian traditional system of medicine which is more than 5000 years old, selected plants have long been classified as ‘medhya…
220 Citations
Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease
- BiologyEvidence-based complementary and alternative medicine : eCAM
- 2021
The primitive remedies as well as the development of herbal remedies for AD management are provided, which may be useful in the discovery and advancement of drugs, thus extending new leads for neurodegenerative diseases such as AD.
Nootropic medicinal plants: Therapeutic alternatives for Alzheimer’s disease
- BiologyJournal of Herbal Medicine
- 2019
Ethnopharmacological review of native traditional medicinal plants for brain disorders
- Medicine
- 2007
Well known medicinal plants of Indian origin, including Withania somnifera, Bacopa monniera, Centella asiatica, Convolvulus pluricaulis, Emblica officinalis and Ocimum sanctum reputed for their effectiveness in CNS disorders are discussed.
Phytochemicals Having Neuroprotective Properties from Dietary Sources and Medicinal Herbs
- Biology
- 2014
The importance of phytochemicals on neuroprotective function and other related disorders, in particular their mechanism of action and therapeutic potential are highlighted.
Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview
- Medicine
- 2020
People who eat more vegetables and fruits may be less risk of developing certain diseases caused by neurological dysfunction, and indication recommends that chronic herbs used to cure neurological symptoms are recommended.
Ayurvedic medicinal plants for Alzheimer's disease: a review
- BiologyAlzheimer's Research & Therapy
- 2012
This review gathers research on various medicinal plants that have shown promise in reversing the Alzheimer's disease pathology and summarizes information concerning the phytochemistry, biological, and cellular activities and clinical applications of these various plants in order to provide sufficient baseline information that could be used in drug discovery campaigns and development process.
Medicinal plants used in traditional Mayan medicine for the treatment of central nervous system disorders: An overview.
- BiologyJournal of ethnopharmacology
- 2021
Neuroprotective potential of phytochemicals
- BiologyPharmacognosy reviews
- 2012
It was observed in the review that a number of herbal medicines used in Ayurvedic practices as well Chinese medicines contain multiple compounds and phytochemicals that may have a neuroprotective effect which may prove beneficial in different neuropsychiatric and neurodegenerative disorders.
Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders
- BiologyPhytotherapy research : PTR
- 2020
A range of traditional plants imparts effects via acetylcholinesterase activity, β‐amyloid peptide formation in plaques, neurotrophic factors and through antioxidant activity, which reveal rich source of primary and secondary metabolites for improving health problems.
HERBAL MEDICINES AS NEUROPROTECTIVE AGENT: A MECHANISTIC APPROACH
- Biology
- 2017
The role of herbal plants and their phytoconstituents against neurodegenerative diseases and other related disorders are highlighted, focusing on their mechanism of action and therapeutic potential.
References
SHOWING 1-10 OF 193 REFERENCES
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders.
- PsychologyLife sciences
- 2004
A review of herbal medicines for psychiatric disorders.
- Medicine, PsychologyPsychiatric services
- 2000
Evidence of the efficacy of herbal preparations in treating psychiatric conditions is growing, but translating the results of efficacy studies into effective treatments for patients is hampered by the chemical complexity of the products, the lack of standardization of commonly available preparations, and the paucity of well-controlled studies.
Potential for interaction of kava and St. John's wort with drugs.
- BiologyJournal of ethnopharmacology
- 2005
Herbal remedies in the United States: potential adverse interactions with anticancer agents.
- Medicine, BiologyJournal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2004
It is suggested that health care professionals and consumers should be aware of the potential for adverse interactions with these herbs, question their patients on their use of them, and urge patients to avoid herbs that could confound their cancer care.
Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability
- PsychologyJournal of psychopharmacology
- 2005
There is a need for longer-term controlled studies with some of these compounds (particularly valerian) and aromatherapy constitutes a tantalising possibility, but how practical a form of treatment this may be remains to be determined.
Adverse-Effect Profile of Kava
- PsychologyCNS Spectrums
- 2001
The data support the safety of kava in treating anxiety at 280 mg kava lactones/day for 4 weeks, including findings from a study of its use in generalized anxiety disorder.
Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
- BiologyPharmacopsychiatry
- 2003
Results suggest that some of the constituents of the non-flavone fraction of EGb 761 possess neuroprotective and anti-apoptotic capacity, and that bilobalide is the most potent one.
Kava extracts: safety and risks including rare hepatotoxicity.
- MedicinePhytomedicine : international journal of phytotherapy and phytopharmacology
- 2003
A critical analysis of the suspected cases in Germany reveals that only in 1 single patient a very probable causal relationship could be established between kava treatment and the development of toxic liver disease due to a positive result of an unscheduled reexposure test, whereas in another patient there might be a possible association.
Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider.
- Psychology, MedicinePhytomedicine : international journal of phytotherapy and phytopharmacology
- 2003
Given the limited therapeutic options for DAT, treatment with EGb still appears to be the method of choice compared to the ChE inhibitors, but the relatively small differences are called into question by the occurrence of drug-specific side effects with the Ch E inhibitors.
A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts.
- Biology, PsychologyPhytomedicine : international journal of phytotherapy and phytopharmacology
- 2003
Some of the controversial evidence derived from clinical and experimental studies suggesting that H. perforatum exerts antidepressant-like actions are reviewed, and some of its side effects, such as nausea, rash, fatigue, restlessness, photosensitivity, acute neuropathy, and even episodes of mania and serotonergic syndrome when administered simultaneously with other antidepressant drugs are reviewed.